Similar to ob/ob mice, DIO mice, which represent a more relevant model for obesity-driven metabolic disease, also displayed increased hepatic protein levels of Grp78 as well as ApoB after treatment with FGF1 (Fig. S6). This evidence concerns the gene FGF1 and Other metabolic disease.